Portuguese pharmaceutical company Bial announced on Tuesday that the Phase 2b (activate) clinical trial evaluating drug BIA 28-6156 in patients with Parkinson’s disease, which was the most [...]
Redundant offices once occupied by the pharmaceutical company AstraZeneca in Barcarena, near Lisbon, have been sold to Oeiras International School (OIS. The property consultants Dils advised on [...]
Drug prices in Portugal will have to rise “sooner or later” due to inflation and political pressure, factors that tend to bring European prices closer to those practiced in the United [...]
The pharmaceutical company Ascendis Pharma has entered the Portuguese market with a focus on rare endocrine diseases. The move is part of the company’s Iberian strategy and its objective of [...]
Organon Pharmaceuticals is expanding its presence in Portugal, having transformed its current center in Lisbon into a Center of Excellence in Business Technology. With 200 people in the country, [...]
AstraZeneca, one of the largest pharmaceutical companies in the world with operations in Portugal since 1999, is to invest €600 million in a new competencies hub in Lisbon. The new hub, located [...]
Can Portugal’s companies survive the times we’re living in today when the EU’s ecological pact is facing multiple challenges? On Wednesday, a European Commission proposal was published to make [...]
The Portuguese pharmaceutical company Bial, which last year celebrated its centenary, is a household name in Portugal and well known in the field of specialised epilepsy and Parkinson’s treatment [...]
Mourad Aboubakr is the new president of pharmaceutical company Novartis Portugal. Already with the company for 15 years, he has a wide experience in the Pharma sector having taken on various [...]
Text: Chris Graeme; Photo: ICPT As the Madonna song goes, “we’re living in a material world” and when the former chairman of arguably Portugal’s most successful and internationally well-known [...]